Premium Market Analysis, Trader Education, Software, and Trading Strategies. Thirty Years Of Skin In The Game

Market Statistics

A Significant Regime Change

Photo by Sebastian Arie Voortman

Gains in the US stock market from regular trading hours since January 2022 turned positive, while there are still significant losses from overnight changes. A regime change has occurred.

In an article last month, I argued that the overnight effect is fading away after providing most of the gain in the US stock market for about three decades.

After the market reversal yesterday, February 1, 2023, due to the Fed’s decision to reduce rate hikes to 25 basis points and dovish interpretations by many analysts, the regular trading hours gains since 2022 turned positive as compared to a large loss from overnight changes.

blank

Specifically, since January 3, 2022, the SPY ETF has gained $1.24 in regular trading hours (green line) versus a loss of $60.52 due to overnight night changes (red line). This is a huge spread in favor of regular trading hours.

Year-to-date, the SPY ETF is up 7.4%, and all of the gains have been realized during regular trading hours, from the open to the close of trading days, or $31.82 versus a loss of $1.84 overnight.

This significant regime change could be related to increased options trading activity during regular trading hours and especially in 0DTE options.

The overnight effect is fading away after the recent publicity it has received, and this is the typical evolution path of most anomalies when the trade gets crowded.


Disclaimer:  The premium articles are provided for informational purposes only and do not constitute investment advice or actionable content. We do not warrant the accuracy, completeness, fitness, or timeliness for any particular purposes of the premium articles. Under no circumstances should the premium articles be treated as financial advice. The author of this website is not a registered financial adviser. The past performance of any trading system or methodology is not necessarily indicative of future results. . Read the full disclaimer here.

Charting and backtesting program: Amibroker. Data provider: Norgate Data